Myriad Genetics MYGN Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's deferred tax assets and other non-current assets?
- Myriad Genetics (MYGN) reported deferred tax assets and other non-current assets of $5.6M in Q1 2026.
- How has Myriad Genetics's deferred tax assets and other non-current assets changed year-over-year?
- Myriad Genetics's deferred tax assets and other non-current assets decreased by 27.3% year-over-year, from $7.7M to $5.6M.
- What is the long-term trend for Myriad Genetics's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Myriad Genetics's deferred tax assets and other non-current assets has grown at a 19.5% compound annual growth rate (CAGR), from $2.3M to $5.6M.